Biotechs Are Down 17% Since Clinton First Put Industry On Blast Last September


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Hillary Clinton is speaking out harshly against the pharmaceutical industry once again, and the market is taking notice. This time, Clinton is lashing out in response to what she calls “outrageous” price gouging on EpiPens by Mylan NV (NASDAQ: MYL).

According to Clinton’s statement, Mylan’s decision to raise the price of EpiPens by 400 percent in the past several years is out of line.

“I believe that our pharmaceutical and biotech industries can be an incredible source of American innovation, giving us revolutionary treatments for debilitating diseases,” Clinton said in a statement. “But it’s wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them.”

Clinton then specifically called on Mylan to lower prices on EpiPens (which they did Thursday morning).

Since Clinton’s remarks, Mylan shares are down 4.7 percent and both the iShares NASDAQ: Biotechnology Index (ETF) (NASDAQ: IBB) and the SPDR S&P Biotech (ETF) (NYSE: XBI) are down more than 3 percent.

Levered biotech ETFs Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) and Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD) have both moved more than 10 percent since Tuesday’s close.

Since Clinton first tweeted about her plan to take on drug price gouging last September, the IBB and the XBI are down 15.6 percent and 18.4 percent, respectively.

At this point, traders must decide whether Clinton’s statements are simply campaign rhetoric designed to get votes in November or whether she intends to butt heads with big pharma if she’s elected. Clinton has a long history of campaigning for healthcare-related issues, so it wouldn’t be surprising to see the issue become one of the centerpieces of a potential Clinton presidency.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechLong IdeasSector ETFsShort IdeasHealth CarePoliticsTop StoriesMoversTrading IdeasETFsGeneralHillary Clinton